ACE Report Cover
Tibial fractures: Alpha-BSM comparable to autogenous bone graft in preventing subsidence
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
TRAUMA
Tibial fractures: Alpha-BSM comparable to autogenous bone graft in preventing subsidence .
Verified
This report has been verified by one or more authors of the original publication.

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2013;1(3):115 J Bone Joint Surg Am. 2008 Oct;90(10):2057-61
Contributing Authors

TA Russell RK Leighton

119 patients presenting with acute, closed, unstable tibial plateau fractures (120 fractures) were randomized to undergo standard open reduction and internal fixation with either a bioresorbable calcium phosphate cement (alpha-BSM) or an autogenous iliac bone graft. The results after a 12 month follow-up indicated that the use of alpha-BSM was superior in reducing articular subsidence compared to autogenous iliac bone graft.


Publication Funding Details +
Funding:
Industry funded
Sponsor:
DePuy and ETEX Corp.
Conflicts:
Other

Risk of Bias

8/10

Reporting Criteria

14/20

Fragility Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Yes = 1

Uncertain = 0.5

Not Relevant = 0

No = 0

The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.

3/4

Randomization

4/4

Outcome Measurements

2/4

Inclusion / Exclusion

3/4

Therapy Description

2/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.

Why was this study needed now?

For patients with defects resulting from unstable tibial plateau fractures, use of the autogenous iliac bone graft is considered the standard choice of treatment. However, there are reported disadvantages and complications associated with this procedure. Prevention of articular surface collapse is the primary goal of autogenous grafting to treat subarticular defects; however, the use of artificial material with internal fixation may provide the necessary benefits and support for the articular surface. Few in vivo studies have demonstrated the benefits of a calcium phosphate cement (alpha-BSM) over bone grafts indicating the need for more trials evaluating the effectiveness of the alpha-BSM.

What was the principal research question?

Is the use of a calcium phosphate cement (alpha-BSM) as effective as autogenous iliac bone graft in the treatment of subarticular bone defects resulting from tibial plateau fractures, measured over a 12 month time period?

Study Characteristics +
Population:
120 acute, closed, unstable tibial plateau fractures (n=119 patients; 73 male, 46 female; average age=43 years).
Intervention:
Bioresorbable group: Patients received open reduction and internal fixation using bioresorbable calcium phosphate cement (alpha-BSM) (n=82 fractures).
Comparison:
Control group: Patients received open reduction and internal fixation using a standard autogenous iliac bone graft (n=38 fractures).
Outcomes:
Fracture union, articular subsidence, loss or premature resorption of graft, infection, effect of tobaco use, and knee range of motion were measured.
Methods:
RCT; Multiple Centres
Time:
Follow up at 6 weeks, 3, 6 and 12 months post-operatively.
What were the important findings?
  • There was no significant difference regarding the age, height, weight, sex and fracture patterns of the patients between the two groups.
  • There was no difference between the two treatment groups with respect to union or the frequency of union, and infections.
  • There was no dissolution in either the bone graft of the alpha-BSM prior to fracture union, evidenced by the absence of radiolucent zones on radiographs. No patients in either of the treatment groups had loss of internal fixation.
  • During the 3-12 month follow up period, the autogenous bone graft group had a significantly higher rate of articular subsidence compared to the alpha-BSM group (subsidence of 2mm or greater in 30% of autogenous graft patients vs. 9% of alpha-BSM patients) (p=0.009).
  • The alpha-BSM group demonstrated a greater improvement in range of motion compared to the autogenous graft group (not significant difference).
What should I remember most?

This study demonstrated that alpha-BSM, for the intervention of tibial plateau fractures, resulted in similar and possibly better mechanical support when compared to autogenous bone grafts, as less subsidence was observed in patients treated with alpha-BSM.

How will this affect the care of my patients?

Patients with unstable tibial plateau fractures may receive comparable outcomes when treated with alpha-BSM compared to autogenous iliac bone graft. As this is one of the first studies investigating alpha-BSM in comparison to autogenous iliac bone graft, further trials are need to establish alpha-BSM as an adequate augmentation to open reduction and internal fixation of unstable tibial plateau fractures.

DISCLAIMER

This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.

0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

How to cite this ACE Report

OrthoEvidence. Tibial fractures: Alpha-BSM comparable to autogenous bone graft in preventing subsidence. OE Journal. 2013;1(3):115. Available from: https://myorthoevidence.com/AceReport/Show/tibial-fractures-alpha-bsm-comparable-to-autogenous-bone-graft-in-preventing-subsidence

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report